Treatment Of Inflammatory Diseases With Mammal Beta Defensins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100016232A1
SERIAL NO

12504930

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to suppression of TNF-alpha activity with mammal beta defensins, which has utility in the treatment of pathological conditions associated with tumor necrosis factor alpha.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVOZYMES ADENIUM BIOTECH A/S2880 BAGSVAERD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andersen, Birgitte Bagsvaerd, DK 24 128
Brinch, Karoline Sidelmann Copenhagen NV, DK 12 65
Kjaer, Tanja Maria Rosenkilde Holte, DK 10 72
Kjaerulff, Soeren Holte, DK 13 89
Kruse, Thomas Copenhagen N, DK 104 757
Mygind, Per Holse Vaerloese, DK 25 167

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation